A research study looking at how different doses of study medicine (Inno8) works in the body of healthy men.
NN7442-7582
Phase 1 other active
Quick answer
A research study looking at how different doses of study medicine (Inno8) works in the body of healthy men. for Prophylaxis and on-demand treatment respectively in patients with haemophilia A with or without FVIII inhibitors. is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Prophylaxis and on-demand treatment respectively in patients with haemophilia A with or without FVIII inhibitors.
- Phase
- Phase 1
- Modality
- other
- Status
- active